Cargando…
Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice
Plasmalogens are a class of glycerophospholipids shown to play critical roles in membrane structure and function. Decreased plasmalogens are reported in the brain and blood of Parkinson’s disease (PD) patients. The present study investigated the hypothesis that augmenting plasmalogens could protect...
Autores principales: | Miville-Godbout, Edith, Bourque, Mélanie, Morissette, Marc, Al-Sweidi, Sara, Smith, Tara, Mochizuki, Asuka, Senanayake, Vijitha, Jayasinghe, Dushmanthi, Wang, Li, Goodenowe, Dayan, Di Paolo, Thérèse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784967/ https://www.ncbi.nlm.nih.gov/pubmed/26959819 http://dx.doi.org/10.1371/journal.pone.0151020 |
Ejemplares similares
-
Plasmalogen deficiency and neuropathology in Alzheimer's disease: Causation or coincidence?
por: Senanayake, Vijitha, et al.
Publicado: (2019) -
Relation of Serum Plasmalogens and APOE Genotype to Cognition and Dementia in Older Persons in a Cross-Sectional Study
por: Goodenowe, Dayan B., et al.
Publicado: (2019) -
Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species
por: Goodenowe, Dayan B., et al.
Publicado: (2022) -
Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study
por: Mankidy, Rishikesh, et al.
Publicado: (2010) -
Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study
por: Senanayake, Vijitha K., et al.
Publicado: (2015)